Literature DB >> 15930521

Membrane transport of anandamide through resealed human red blood cell membranes.

Inge N Bojesen1, Harald S Hansen.   

Abstract

The use of resealed red blood cell membranes (ghosts) allows the study of the transport of a compound in a nonmetabolizing system with a biological membrane. Transmembrane movements of anandamide (N-arachidonoylethanolamine, arachidonoylethanolamide) have been studied by exchange efflux experiments at 0 degrees C and pH 7.3 with albumin-free and albumin-filled human red blood cell ghosts. The efflux kinetics is biexponential and is analyzed in terms of compartment models. The distribution of anandamide on the membrane inner to outer leaflet pools is determined to be 0.275 +/- 0.023, and the rate constant of unidirectional flux from inside to outside is 0.361 +/- 0.023 s(-1). The rate constant of unidirectional flux from the membrane to BSA in the medium ([BSA]o) increases with the square root of [BSA]o in accordance with the theory of an unstirred layer around ghosts. Anandamide passed through the red blood cell membrane very rapidly, within seconds. At a molar ratio of anandamide to BSA of <1, membrane binding of anandamide increases with increasing temperatures between 0 degrees C and 37 degrees C, and the equilibrium dissociation constants are in the nanomolar range. The nature of membrane binding and the mechanism of membrane translocation are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930521     DOI: 10.1194/jlr.M400498-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

1.  Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.

Authors:  L Thors; J Eriksson; C J Fowler
Journal:  Br J Pharmacol       Date:  2007-08-06       Impact factor: 8.739

Review 2.  Endocannabinoid liberation from neurons in transsynaptic signaling.

Authors:  David M Lovinger
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

Review 3.  Endocannabinoids and the haematological system.

Authors:  M D Randall
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

Review 4.  2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook.

Authors:  Anita Hermann; Martin Kaczocha; Dale G Deutsch
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

Review 5.  The rise and fall of anandamide: processes that control synthesis, degradation, and storage.

Authors:  Roger Gregory Biringer
Journal:  Mol Cell Biochem       Date:  2021-03-13       Impact factor: 3.396

6.  The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.

Authors:  L Thors; K Alajakku; C J Fowler
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

7.  Is there a temperature-dependent uptake of anandamide into cells?

Authors:  L Thors; C J Fowler
Journal:  Br J Pharmacol       Date:  2006-07-24       Impact factor: 8.739

8.  Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter.

Authors:  Alessia Ligresti; Luciano De Petrocellis; Dolores Hernán Pérez de la Ossa; Rosario Aberturas; Luigia Cristino; Aniello Schiano Moriello; Andrea Finizio; M Esther Gil; Ana-Isabel Torres; Jesús Molpeceres; Vincenzo Di Marzo
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

9.  Oral ibuprofen differentially affects plasma and sweat lipid mediator profiles in healthy adult males.

Authors:  Karan Agrawal; Rémy Bosviel; Brian D Piccolo; John W Newman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-05-17       Impact factor: 3.072

10.  Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion.

Authors:  Martin Kaczocha; Qingqing Lin; Lindsay D Nelson; Michelle K McKinney; Benjamin F Cravatt; Erwin London; Dale G Deutsch
Journal:  ACS Chem Neurosci       Date:  2012-01-18       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.